Calidi Biotherapeutics, Inc.

8-K Modified rights of security holders; Amended charter or bylaws Jul 31, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Jul 16, 2026 8-K Director or officer change; Regulation FD disclosure; Other events Jun 23, 2026 8-K Shareholder vote results Jun 18, 2026 8-K Entered a material agreement; Unregistered sale of equity May 29, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2026 8-K Entered a material agreement; Unregistered sale of equity May 8, 2026 8-K Director or officer change; Other events Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 27, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 11, 2026 8-K Regulation FD disclosure Feb 10, 2026 8-K Results of operations (earnings release); Other events Jan 29, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 8-K Regulation FD disclosure; Other events Nov 10, 2025 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition Oct 31, 2025 8-K Regulation FD disclosure; Other events Oct 24, 2025 8-K Entered a material agreement; Director or officer change Sep 19, 2025 8-K Regulation FD disclosure Aug 29, 2025 8-K Entered a material agreement; Other events Aug 22, 2025 8-K Entered a material agreement; Director or officer change Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2025 8-K Modified rights of security holders; Amended charter or bylaws Aug 7, 2025 8-K Director or officer change; Regulation FD disclosure; Other events Jul 25, 2025 8-K Shareholder vote results Jul 11, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Changed accountants May 2, 2025 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure; Other events Apr 23, 2025 8-K Regulation FD disclosure Apr 10, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 1, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Regulation FD disclosure Mar 10, 2025 8-K/A Feb 10, 2025 8-K Other events Feb 5, 2025